Research on potential biomarkers in hereditary hemorrhagic telangiectasia

por Botella, Luisa-María, Albiñana, Virginia, Ojeda-Fernandez, Luisa, Recio-Poveda, Lucia, Bernabéu, Carmelo
Publicado 2015

Sclerotherapy on Demand with Polidocanol to Treat HHT Nosebleeds

por Marcos, Sol, Botella, Luisa María, Albiñana, Virginia, Arbia, Agustina, de Rosales, Anna María
Publicado 2021

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)

por Zarrabeitia, Roberto, Fariñas-Álvarez, Concepción, Santibáñez, Miguel, Señaris, Blanca, Fontalba, Ana, Botella, Luisa María, Parra, José Antonio
Publicado 2017

eHealth for patients with rare diseases: the eHealth Working Group of the European Reference Network on Rare Multisystemic Vascular Diseases (VASCERN)

por Paglialonga, Alessia, Gaetano, Raffaella, Robert, Leema, Hurard, Marine, Botella, Luisa Maria, Barr, Natasha, Jondeau, Guillaume, Pini, Alessandro
Publicado 2021

Blockade of β2-Adrenergic Receptor Reduces Inflammation and Oxidative Stress in Clear Cell Renal Cell Carcinoma

por Albiñana, Virginia, Recio-Poveda, Lucía, González-Peramato, Pilar, Martinez-Piñeiro, Luis, Botella, Luisa María, Cuesta, Angel M.
Publicado 2022

The Role of Propranolol as a Repurposed Drug in Rare Vascular Diseases

por Cuesta, Angel M., Gallardo-Vara, Eunate, Casado-Vela, Juan, Recio-Poveda, Lucía, Botella, Luisa-María, Albiñana, Virginia
Publicado 2022

Propranolol: A “Pick and Roll” Team Player in Benign Tumors and Cancer Therapies

por Albiñana, Virginia, Gallardo-Vara, Eunate, Casado-Vela, Juan, Recio-Poveda, Lucía, Botella, Luisa María, Cuesta, Angel M
Publicado 2022

CLN5 in heterozygosis may protect against the development of tumors in a VHL patient

por de Rojas-P, Isabel, Albiñana, Virginia, Recio-Poveda, Lucía, Rodriguez-Rufián, Amanda, Cuesta, Ángel M., Botella, Luisa-María
Publicado 2020

SARS-CoV-2 Infection in Hereditary Hemorrhagic Telangiectasia Patients Suggests Less Clinical Impact Than in the General Population

por Marcos, Sol, Albiñana, Virginia, Recio-Poveda, Lucia, Tarazona, Belisa, Verde-González, María Patrocinio, Ojeda-Fernández, Luisa, Botella, Luisa-María
Publicado 2021

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

por Albiñana, Virginia, Cuesta, Angel M., de Rojas-P, Isabel, Gallardo-Vara, Eunate, Recio-Poveda, Lucía, Bernabéu, Carmelo, Botella, Luisa María
Publicado 2020

Case Report: Propranolol increases the therapeutic response to temozolomide in a patient with metastatic paraganglioma

por Díaz-Castellanos, Miguel-Angel, Gómez de las Heras, Karina Villar, Díaz-Redondo, Tamara, González-Flores, Encarnación, Albiñana, Virginia, Botella, Luisa-María
Publicado 2017

Topically Applied Etamsylate: A New Orphan Drug for HHT-Derived Epistaxis (Antiangiogenesis through FGF Pathway Inhibition)

por Albiñana, Virginia, Giménez-Gallego, Guillermo, García-Mato, Angela, Palacios, Patricia, Recio-Poveda, Lucia, Cuesta, Angel-M, Patier, José-Luis, Botella, Luisa-María
Publicado 2019

Raloxifene and n-Acetylcysteine Ameliorate TGF-Signalling in Fibroblasts from Patients with Recessive Dominant Epidermolysis Bullosa

por Aguado, Tania, García, Marta, García, Adela, Ferrer-Mayorga, Gemma, Martínez-Santamaría, Lucía, del Río, Marcela, Botella, Luisa-María, Sánchez-Puelles, José-María
Publicado 2020

Repurposing propranolol as a drug for the treatment of retinal haemangioblastomas in von Hippel-Lindau disease

por Albiñana, Virginia, Escribano, Rosa María Jiménez, Soler, Isabel, Padial, Luis Rodríguez, Recio-Poveda, Lucia, Villar Gómez de las Heras, Karina, Botella, Luisa María
Publicado 2017

A Novel Splicing Mutation in the ACVRL1/ALK1 Gene as a Cause of HHT2

por Errasti Díaz, Suriel, Peñalva, Mercedes, Recio-Poveda, Lucía, Vilches, Susana, Casado-Vela, Juan, Pérez Pérez, Julián, Botella, Luisa María, Albiñana, Virginia, Cuesta, Angel M.
Publicado 2022

Safety of thalidomide and bevacizumab in patients with hereditary hemorrhagic telangiectasia

por Buscarini, Elisabetta, Botella, Luisa Maria, Geisthoff, Urban, Kjeldsen, Anette D., Mager, Hans Jurgen, Pagella, Fabio, Suppressa, Patrizia, Zarrabeitia, Roberto, Dupuis-Girod, Sophie, Shovlin, Claire L.
Publicado 2019

Identification of Exosomal MicroRNA Signature by Liquid Biopsy in Hereditary Hemorrhagic Telangiectasia Patients

por Pozo-Agundo, Ana, Villaescusa, Nerea, Martorell-Marugán, Jordi, Soriano, Olga, Leyva, Socorro, Jódar-Reyes, Ana Belén, Botella, Luisa María, Carmona-Sáez, Pedro, Blanco, Francisco Javier
Publicado 2021

Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients

por Albiñana, Virginia, Villar Gómez de las Heras, Karina, Serrano-Heras, Gemma, Segura, Tomás, Perona-Moratalla, Ana Belén, Mota-Pérez, Mercedes, de Campos, José María, Botella, Luisa María
Publicado 2015

Targeting β2-Adrenergic Receptors Shows Therapeutical Benefits in Clear Cell Renal Cell Carcinoma from Von Hippel–Lindau Disease

por Albiñana, Virginia, Gallardo-Vara, Eunate, de Rojas-P, Isabel, Recio-Poveda, Lucia, Aguado, Tania, Canto-Cano, Ana, Aguirre, Daniel T., Serra, Marcelo M., González-Peramato, Pilar, Martínez-Piñeiro, Luis, Cuesta, Angel M., Botella, Luisa Maria
Publicado 2020

11PS04 is a new chemical entity identified by microRNA-based biosensing with promising therapeutic potential against cancer stem cells

por Aguado, Tania, Romero-Revilla, José A., Granados, Rosario, Campuzano, Susana, Torrente-Rodríguez, Rebeca M., Cuesta, Ángel M., Albiñana, Virginia, Botella, Luisa María, Santamaría, Silvia, Garcia-Sanz, Jose A., Pingarrón, José Manuel, Sánchez-Sancho, Francisco, Sánchez-Puelles, José-María
Publicado 2019